Gene · 4192
Papers2,993
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,993
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Elevated Midkine Serum Levels Are Associated with Long-Term Survival in Critically Ill Patients. | Int J Mol Sci | 2023 | 38203625 | PubTator, text mining | PubMed |
| Machine Learning and Single-Cell Analysis Identify Molecular Features of IPF-Associated Fibroblast Subtypes and Their Implications on IPF Prognosis. | Int J Mol Sci | 2023 | 38203265 | PubTator, text mining | PubMed |
| Crosstalk between neutrophil extracellular traps and immune regulation: insights into pathobiology and therapeutic implications of transfusion-related acute lung injury. | Front Immunol | 2023 | 38162674 | PubTator, text mining | PubMed |
| Analysis of cancer-associated fibroblasts in cervical cancer by single-cell RNA sequencing. | Aging (Albany NY) | 2023 | 38157264 | PubTator, text mining | PubMed |
| Single-cell RNA-seq identified novel genes involved in primordial follicle formation. | Front Endocrinol (Lausanne) | 2023 | 38149096 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing analysis of lung cells in COVID-19 patients with diabetes, hypertension, and comorbid diabetes-hypertension. | Front Endocrinol (Lausanne) | 2023 | 38144556 | PubTator, text mining | PubMed |
| Chemically induced revitalization of damaged hepatocytes for regenerative liver repair. | iScience | 2023 | 38144457 | PubTator, text mining | PubMed |
| The Association of Serum Midkine Level with Invasion in Placenta Previa: A Case-Control Study from a Tertiary Reference Center. | J Interferon Cytokine Res | 2023 | 38126935 | PubTator, text mining | PubMed |
| Type 1 diabetes mellitus: Roles of neutrophils in the pathogenesis. | Medicine (Baltimore) | 2023 | 38115297 | PubTator, text mining | PubMed |
| Harnessing immunotherapy for brain metastases: insights into tumor-brain microenvironment interactions and emerging treatment modalities. | J Hematol Oncol | 2023 | 38104104 | PubTator, text mining | PubMed |
| The role of midkine in health and disease. | Front Immunol | 2023 | 38098484 | PubTator, text mining | PubMed |
| Targeting the myeloid microenvironment in neuroblastoma. | J Exp Clin Cancer Res | 2023 | 38087370 | PubTator, text mining | PubMed |
| Mesenchymal ovarian cancer cells promote CD8+ T cell exhaustion through the LGALS3-LAG3 axis. | NPJ Syst Biol Appl | 2023 | 38086828 | PubTator, text mining | PubMed |
| Machine learning identified MDK score has prognostic value for idiopathic pulmonary fibrosis based on integrated bulk and single cell expression data. | Front Genet | 2023 | 38075691 | PubTator, text mining | PubMed |
| The emerging role of glycolysis and immune evasion in gastric cancer. | Cancer Cell Int | 2023 | 38071310 | PubTator, text mining | PubMed |
| Expression Profiles of Genes Related to Development and Progression of Endometriosis and Their Association with Paraben and Benzophenone Exposure. | Int J Mol Sci | 2023 | 38069001 | PubTator, text mining | PubMed |
| Recent Advances in Surface Plasmon Resonance (SPR) Technology for Detecting Ovarian Cancer Biomarkers. | Cancers (Basel) | 2023 | 38067311 | PubTator, text mining | PubMed |
| Delineating the early dissemination mechanisms of acral melanoma by integrating single-cell and spatial transcriptomic analyses. | Nat Commun | 2023 | 38065972 | PubTator, text mining | PubMed |
| Microglia Polarization and Antiglioma Effects Fostered by Dual Cell Membrane-Coated Doxorubicin-Loaded Hexagonal Boron Nitride Nanoflakes. | ACS Appl Mater Interfaces | 2023 | 38051559 | PubTator, text mining | PubMed |
| Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy. | MedComm (2020) | 2023 | 38045829 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4192/papers?page=18